Remote Monitoring to Prevent Frailty Progression in the Elderly
NCT ID: NCT05173870
Last Updated: 2023-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10 participants
OBSERVATIONAL
2023-06-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
NCT05961319
Home-based Empowerment Through Physical Exercise Assisted by Technology for Frail Patients
NCT07118761
Comprehensive Validation of Frailty Assessment Tools in Older Adults in Different Clinical and Social Settings
NCT02637518
Optimizing Prevention of Hospital-Acquired Disability Through Multidomain Interventions
NCT06611228
Non-invasive, Wearable Multi-parameter System for the Early Prediction of Cognitive Decline and Dementia in Older Adults
NCT04262674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this context, the primary aim of the present pilot study is to standardize a study protocol to develop a useful model to enhance local care in small population isolates, by remotely monitoring the health status of pre-frail subjects and to improve the progression of the frailty condition, in order to support a healthy ageing for future investigation including a larger number of individuals.
Additional aims:
* To quantify the timeframes necessary for the subjects recruiting and examination activities,including questionnaires and functional tests administration;
* To quantify the training time needed to explain the use of the wearable device to the recruited elderly individuals;
* To assess the responsiveness of pre-frail subjects, during the preliminary screening, the examination visit and the monitoring period (follow-up 6 months);
* To evaluate the compliance of pre-frail individuals with the use of the wearable device.
All men and women aged \>= 65 years, resident a small mountain village (Salcito) in Molise region, Italy, will be invited to participate at the first examination, in order to evaluate their frailty condition, in a specific way their pre-frail/frail condition.
In the screening phase, in particular, it will be used the AGILE score to select the subjects to be included in the study. The questionnaire is a frailty tool that allows to quickly identify elderly, but also to investigate "multidimensional" frailty. It is built by selecting among the 40 items of the italian frailty index, the 10 ones most predictive of mortality. Therefore the questionnaire is composed by 10 items with a dychotomous answer (yes/no), in order to homogenously represent the four domains of frailty: physical, mental, nutrirional and socio-economic. After the preliminary screening, 30 elderly with pre-frailty will be randomly selected to be equipped with the wearable devices (such as smartband and smart-clothes ).The wearable devices have a biosensor able to daily collect,in a remote way, many biometric measurements such as: blood pressure, body temperature, heart and respiratory rate, posture and sleep quality.
During the baseline visit, the 30 pre-frail elderly will be trained to the use of the wearable devices. In addition, others questionnaires will be administered to collect information on their dietary habits, lifestyles, cognitive assessment and clinical history of the major chronic disease (CVD, cancer…). Additionally, during the baseline visit of recruited 30 pre-frail subjects, a venous blood sample will be collected. This will be used to measure biochemical and molecular parameters. In particular, samples will be analyzed to study potential biomarkers of pre-frailty/frailty condition. An aliquot of the biological sample will be stored in liquid nitrogen in a dedicated biobank of IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) NEUROMED, for any future molecular analysis.
Thanks to the wearable devices, individuals will be monitored constantly for six months, from a health point of view.
In the early stages of recruitment it will be possible to identify any critical issues in the training procedures of individuals over 65 recruited to use the wearable device.
During the six months period of monitoring, it will be possible to evaluate the compliance of subjects recruited to the wearable device use. In particular, it could be possible to evaluate the reliability of collected data thanks to the device and eventually make changes in operative procedures, when needed. If, during the monitoring, an abnormal parameter value will be observed, it will be communicated both to the subject and to his physician, with the aim of promoting a greater attention to personal health. In this way it could be possible to ensure a better quality of life. During six months, participants will be called back every other month, in order to evaluate the status of devices. After six months, participants will be called back for a follow-up visit, during which all the test, the questionnaires and the blood sample collection will be repeated to evaluate the potential impact of monitoring, on their condition.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wearable device
The wearable devices has a biosensor able to daily collect,in a remote way, many biometric measurements such as: blood pressure, blood oxygenation, heart and respiratory rate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Salcito (a small mountain village in Molise region) residents.
Exclusion Criteria
* Individuals affected by physical or mental diseases, pacemaker or other medical device keeper who make the use of "wearable device" not possible or unable to complete functional tests.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Molise
OTHER
Neuromed IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Licia Iacoviello
Head of the Department of Epidemiology and Prevention
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Licia Iacoviello, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Neuromed
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS INM Neuromed, Department of Epidemiology and Prevention
Pozzilli, IS, Italy
IRCCS Neuromed
Pozzilli, IS, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Roberta Parisi, BSc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEP_022021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.